deltatrials
Completed NCT01128010

Role of CCL2 in Alcoholic Liver Diseases

Sponsor: Erasme University Hospital

Updated 5 times since 2017 Last updated: May 20, 2010

A observational or N/A phase clinical study on Alcoholic Liver Disease, this trial is completed. The trial is conducted by Erasme University Hospital and has accumulated 5 data snapshots since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Apr 2018 — Jan 2021 [monthly]

    Completed

    Phase: NANone

  5. Jan 2017 — Apr 2018 [monthly]

    Completed NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Erasme University Hospital
Data source: Erasme University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.